Picture of Sihuan Pharmaceutical Holdings logo

460 Sihuan Pharmaceutical Holdings Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual income statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
R2019
December 31st
2020
December 31st
R2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,9172,8782,4643,0382,181
Cost of Revenue
Gross Profit2,3792,2891,9142,4301,488
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses8915,2851,6772,2664,012
Operating Profit2,026-2,406787772-1,831
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes2,012-2,423766496-2,123
Provision for Income Taxes
Net Income After Taxes1,679-2,713547243-2,320
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income1,620-2,753473417-1,915
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,620-2,753473417-1,915
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.171-0.0140.0420.048-0.101
Dividends per Share
Special Dividends per Share